Phase 3 Safety Study of LNZ100 and LNZ101 for the Treatment of Presbyopia Subjects
Clinical trial NCT05753189 · COMPLETED
Trial details
- NCT number
- NCT05753189
- Sponsor
- LENZ Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-21
- Primary completion
- 2024-02-09
- Enrollment
- 362
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.